Investor Hillhouse Capital Advisors, Ltd.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Hillhouse Capital Advisors, Ltd. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-05-13 13D/A ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 92,805,741 68,551,141
2025-03-03 13D/A ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 125,045,741 92,805,741
2025-02-14 13G/A API / Agora, Inc. - Depositary Receipt (Common Stock) 19,287,300 8,394,212
2024-12-04 13D/A ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 147,043,058 125,045,741
2024-11-14 13G/A ALGS / Aligos Therapeutics, Inc. 5,971,426 125,069
2024-11-14 13G/A KNSA / Kiniksa Pharmaceuticals, Ltd. 3,879,426 1,582,635
2024-11-14 13G AVBP / ArriVent BioPharma, Inc. 4,484,672
2024-02-14 13G/A EM / Smart Share Global Limited - Depositary Receipt (Common Stock) 62,627,893 62,367,293
2024-02-14 13G/A KNSA / Kiniksa Pharmaceuticals, Ltd. 3,541,301 3,879,426
2024-02-14 13G/A CTKB / Cytek Biosciences, Inc. 8,684,530 6,657,030
2024-02-14 13G/A BEDU / Bright Scholar Education Holdings Limited - Depositary Receipt (Common Stock) 3,985,796 3,952,572
2024-02-14 13G/A MOGU / MOGU Inc. - Depositary Receipt (Common Stock) 261,174,005 254,253,005
2024-02-14 13G/A ALGS / Aligos Therapeutics, Inc. 2,309,764 5,971,426
2024-02-14 13G/A API / Agora, Inc. - Depositary Receipt (Common Stock) 20,000,000 19,287,300
2023-08-18 13G/A KNSA / Kiniksa Pharmaceuticals, Ltd. 2,623,924 3,541,301
2023-06-30 13D/A IMAB / I-Mab - Depositary Receipt (Common Stock) 16,520,560 15,891,211
2023-02-14 13G/A ALGS / Aligos Therapeutics, Inc. 2,365,064 2,309,764
2023-02-14 13G/A ROOT / Root, Inc. 7,087,405 138,977
2023-02-14 13G/A CTKB / Cytek Biosciences, Inc. 8,757,030 8,684,530
2023-02-14 13G/A ONON / On Holding AG 15,973,750 5,468,504
2023-02-14 13D/A BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock) 147,035,258 147,043,058
2023-02-14 13G/A GOSS / Gossamer Bio, Inc. 7,420,974 4,974,041
2023-02-14 13G/A MOGU / MOGU Inc. - Depositary Receipt (Common Stock) 261,174,255 261,174,005
2023-02-14 13G/A KNSA / Kiniksa Pharmaceuticals, Ltd. 2,920,023 2,623,924
2023-02-14 13G/A BEDU / Bright Scholar Education Holdings Limited - Depositary Receipt (Common Stock) 3,985,797 3,985,796
2023-02-14 13G/A YSG / Yatsen Holding Limited - Depositary Receipt (Common Stock) 322,610,654 300,560,602
2022-08-16 13D/A BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock) 147,035,258 147,035,258
2022-07-11 13G/A IQ / iQIYI, Inc. - Depositary Receipt (Common Stock) 270,539,345 149,075,912
2022-02-14 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 8,927,663 0
2022-02-14 13G API / Agora, Inc. - Depositary Receipt (Common Stock) 20,000,000
2022-02-14 13G/A BEKE / KE Holdings Inc. - Depositary Receipt (Common Stock) 176,255,685 89,085,195
2022-02-14 13G ONON / On Holding AG 15,973,750
2022-02-14 13G / Cytek Biosciences, Inc. 8,757,030
2022-02-14 13G/A MNSO / MINISO Group Holding Limited - Depositary Receipt (Common Stock) 60,401,152 1,009,290
2022-02-14 13G/A APLS / Apellis Pharmaceuticals, Inc. 5,028,289 0
2022-02-14 13G/A ALGS / Aligos Therapeutics, Inc. 2,165,064 2,365,064
2022-02-14 13G/A FUTU / Futu Holdings Limited - Depositary Receipt (Common Stock) 1,200,000
2022-02-14 13G/A YSG / Yatsen Holding Limited - Depositary Receipt (Common Stock) 342,284,052 322,610,654
2022-02-14 13G/A LPTX / Leap Therapeutics, Inc. 3,716,240 0
2022-02-14 13G/A BEAM / Beam Therapeutics Inc. 2,966,403 0
2022-02-14 13G/A ROOT / Root, Inc. 4,468,917 7,087,405
2021-09-27 13D/A IMAB / I-Mab - Depositary Receipt (Common Stock) 19,050,560 16,520,560
2021-09-27 13G / SMART SHARE GLOBAL LTD ADR 62,627,893
2021-07-19 13D/A ESGR / Enstar Group Limited 543,487 0
2021-06-24 13D/A IMAB / I-Mab - Depositary Receipt (Common Stock) 19,050,560 19,050,560
2021-04-22 13D/A 16938C106 / China Biologic Products, Inc. 2,962,076 0
2021-03-25 13D/A IMAB / I-Mab - Depositary Receipt (Common Stock) 22,492,602 19,050,560
2021-02-16 13G/A TAL / TAL Education Group - Depositary Receipt (Common Stock) 9,151,656 8,927,663
2021-02-16 13G/A APLS / Apellis Pharmaceuticals, Inc. 4,678,289 5,028,289
2021-02-16 13G/A BILI / Bilibili Inc. - Depositary Receipt (Common Stock) 10,215,355 5,067,027
2021-02-16 13G/A US9266131005 / Viela Bio, Inc. 4,591,176 2,382,414
2021-02-16 13G FUTU / Futu Holdings Limited - Depositary Receipt (Common Stock) 1,200,000
2021-02-16 13G ROOT / Root, Inc. 4,468,917
2021-02-16 13G ALGS / Aligos Therapeutics, Inc. 2,165,064
2021-02-16 13G LPTX / Leap Therapeutics, Inc. 3,716,240
2021-02-16 13G/A KNSA / Kiniksa Pharmaceuticals, Ltd. 1,895,888 2,920,023
2021-02-16 13G BEAM / Beam Therapeutics Inc. 2,966,403
2021-02-16 13G/A IQ / iQIYI, Inc. - Depositary Receipt (Common Stock) 326,862,409 270,539,345
2021-02-16 13G BEKE / KE Holdings Inc. - Depositary Receipt (Common Stock) 176,255,685
2021-02-16 13G MNSO / MINISO Group Holding Limited - Depositary Receipt (Common Stock) 60,401,152
2021-02-16 13G/A GOSS / Gossamer Bio, Inc. 5,911,541 7,420,974
2021-02-16 13G/A YSG / Yatsen Holding Limited - Depositary Receipt (Common Stock) 342,284,052
2020-12-21 13D/A IMAB / I-Mab - Depositary Receipt (Common Stock) 10,586,008 22,492,602
2020-12-16 13G YSG / Yatsen Holding Limited - Depositary Receipt (Common Stock) 350,744,474
2020-11-23 13D/A 16938C106 / China Biologic Products, Inc. 2,962,076 2,962,076
2020-10-28 13D/A 16938C106 / China Biologic Products, Inc. 2,962,076 2,962,076
2020-09-18 13D/A 16938C106 / China Biologic Products, Inc. 2,962,076 2,962,076
2020-09-14 13D IMAB / I-Mab - Depositary Receipt (Common Stock) 10,586,008
2020-07-14 13D/A BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock) 63,117,389 147,035,258
2020-06-24 13D/A US15117P1021 / Cellular Biomedicine Group, Inc. 235,214 235,214
2020-05-08 13D/A 16938C106 / China Biologic Products, Inc. 2,962,076 2,962,076
2020-03-30 13D/A US15117P1021 / Cellular Biomedicine Group, Inc. 235,214 235,214
2020-02-21 13D/A US15117P1021 / Cellular Biomedicine Group, Inc. 235,214 235,214
2020-02-14 13G/A IQ / iQIYI, Inc. - Depositary Receipt (Common Stock) 7,929,712 326,862,409
2020-02-14 13G/A KNSA / Kiniksa Pharmaceuticals, Ltd. 1,388,888 1,895,888
2020-02-14 13G/A MOGU / MOGU Inc. - Depositary Receipt (Common Stock) 130,587,127 261,174,255
2020-02-14 13G TAL / TAL Education Group - Depositary Receipt (Common Stock) 9,151,656
2020-02-14 13G BILI / Bilibili Inc. - Depositary Receipt (Common Stock) 10,215,355
2020-02-14 13G/A APLS / Apellis Pharmaceuticals, Inc. 2,229,708 4,678,289
2020-02-14 13G GOSS / Gossamer Bio, Inc. 5,911,541
2020-02-14 13G US9266131005 / Viela Bio, Inc. 4,591,176
2020-01-30 13D/A US15117P1021 / Cellular Biomedicine Group, Inc. 235,214 235,214
2020-01-27 13D/A 16938C106 / China Biologic Products, Inc. 2,751,200 2,962,076
2019-11-12 13D US15117P1021 / Cellular Biomedicine Group, Inc. 235,214
2019-09-19 13D 16938C106 / China Biologic Products, Inc. 2,751,200 2,751,200
2019-04-02 13D/A ESGR / Enstar Group Limited 543,487
2019-02-14 13G/A IQ / iQIYI, Inc. - Depositary Receipt (Common Stock) 7,929,712
2019-02-14 13G/A 16938C106 / China Biologic Products, Inc. 2,751,200
2019-02-14 13G/A BEDU / Bright Scholar Education Holdings Limited - Depositary Receipt (Common Stock) 3,985,797
2019-02-14 13G/A APLS / Apellis Pharmaceuticals, Inc. 2,229,708
2019-02-14 13G KNSA / Kiniksa Pharmaceuticals, Ltd. 1,388,888
2019-01-10 13G MOGU / MOGU Inc. - Depositary Receipt (Common Stock) 130,587,127
2019-01-03 13D/A BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock) 63,117,389